COMMON STOCK PURCHASE WARRANT NEUBASE THERAPEUTICS, INC.Common Stock Purchase Warrant • June 23rd, 2021 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July ___, 20231 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NeuBase Therapeutics, Inc., a Delaware corporation (the “Company”), up to 105,000 shares of the Company’s Common Stock (as subject to adjustment hereunder, the “Warrant Shares”); provided that this Warrant may only be exercised for Warrant Shares that are deemed Vested under this Warrant. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
